WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced that it will participate in two upcoming healthcare conferences in September to highlight corporate updates and its development strategy.
The company’s Chief Executive Officer, Dr. Neal Walker, along with senior leadership, will take part in a fireside chat during the Cantor Global Healthcare Conference on Wednesday, September 3, 2025, at 1:00 p.m. EDT in New York.
On Tuesday, September 9, 2025, at 9:00 a.m. EDT, Dr. Walker will also deliver a corporate presentation at the H.C. Wainwright 27th Annual Global Investment Conference, also in New York.
Live and archived webcasts of both events will be accessible through the company’s website and available for at least 30 days.
Aclaris Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for immuno-inflammatory diseases with limited treatment options.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.